加拿大研发的抗新冠病毒新药

[和风溪流]

UBC professor uses knowledge of SARS to develop COVID-19 drug | Globalnews.ca

Dr. Josef Penninger, a UBC life sciences institute director, co-discovered an enzyme called ACE2 while working as a researcher in Toronto in the late 90s.

globalnews.ca

 

[向问天]

还记得加拿大的那个5分钟检测病毒的仪器吗？

 

[贵圈]

新药？拿的通过三期，通过FDA之类的。。。
慢慢等吧。过去半年，临床测试了没？

 

[Jay Wang]

先别恢心，拿大的科研还是很牛B的

 

[向问天]

需要常识。
两天消灭病毒是不可能的，除非你找到像抗菌素对付细菌那样的特效药。

 

[向问天]

我宁愿相信5分钟检测病毒。

 

[贵圈]

渥太华的骄傲，现在在哪里？没消息了。
后来不是还有那个空气real-time测毒？加拿大的骄傲，卖了几台？都谁买了？哈啊哈

 

[lindamy]

BC的那个漱口液测试现在怎么样了？也是世界第一的，可以推广吗？

 

[向问天]

美国死人数量放卫星。
加拿大科技放卫星。
还真是一对难兄难弟啊。

 

[ztbll]

美国死人数量放卫星。
加拿大科技放卫星。
还真是一对难兄难弟啊。

你这二逼有没有耐心以及能力读懂一篇科普性质的新闻？其实人家的思路是正确的，和羟氯奎的思路接近。

 

[向问天]

你这二逼有没有耐心以及能力读懂一篇科普性质的新闻？其实人家的思路是正确的，和羟氯奎的思路接近。

你个傻逼，羟化溃已经失败了。
印度巴西美国，几个推崇羟化溃的国家死人最多。
你的例子证明了你的愚蠢。
滚！

 

[ztbll]

你个傻逼，羟化溃已经失败了。
印度巴西美国，几个推崇羟化溃的国家死人最多。
你的例子证明了你的愚蠢。
滚！

你个煞笔，那么多医生病人自己现身说法，不是黑暗势力能抹杀的。 羟氯奎对早期降低重症，死亡率的效果是明显的。打压的都是来自高层的，怀着各自不可告人的目的而已。

 

[gocanoeing]

看起来有前景
-------------------------------------------------------
On Thursday, the promising findings of the first clinical trial of his new treatment were released in the Lancet Medical Journal.

The patient, a 45-year-old woman in Vienna who was on a ventilator due to severe COVID-19 symptoms, showed improvement shortly after receiving the drug known as APN01.

“In one or two days, the virus disappeared in her blood system and also in her lungs,” Penninger told Global News. “Secondly, the cytokine storm went down within two to three days. She developed perfect immunity from the virus.”

“She is now back home and healthy.”

A cytokine storm is an overreaction of the body’s immune system, which can be fatal if someone has COVID-19.

Study recruitment is still underway around the world, with the hope that the results from 200 other severe cases of COVID-19 patients will be published by November.

If all goes well, Penninger said there could be a drug ready for market by early next year.

 

[gocanoeing]

看起来有前景
-------------------------------------------------------
On Thursday, the promising findings of the first clinical trial of his new treatment were released in the Lancet Medical Journal.

The patient, a 45-year-old woman in Vienna who was on a ventilator due to severe COVID-19 symptoms, showed improvement shortly after receiving the drug known as APN01.

“In one or two days, the virus disappeared in her blood system and also in her lungs,” Penninger told Global News. “Secondly, the cytokine storm went down within two to three days. She developed perfect immunity from the virus.”

“She is now back home and healthy.”

A cytokine storm is an overreaction of the body’s immune system, which can be fatal if someone has COVID-19.

Study recruitment is still underway around the world, with the hope that the results from 200 other severe cases of COVID-19 patients will be published by November.

If all goes well, Penninger said there could be a drug ready for market by early next year.

这是发表在 Lancet Medical Journal，顶级医学期刊，不是闫博士发论文的那种三无平台，可信度天地之差 @livingeverywhere

 

[gocanoeing]

你真逗，是来CFC装逼的吧

这个没办法，比起 Lancet，闫博士发论文的确是在三无平台啊，可信度和CFC类似